Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nakamura H et al. – Risk of CVD is higher in patients with moderate CKD compared with those with normal renal function/mild CKD, and was significantly reduced by treatment with pravastatin. Pravastatin also exerted beneficial effects on renal function in patients with moderate CKD.

Related Articles

The impact of renal insufficiency and anaemia on survival in patients with cardiovascular disease: a cohort study
BMC Cardiovascular Disorders, 11/13/09    Relevance Score: 94%

Is normalising haemoglobin in patients with CKD harmful and if so, why
Journal of Renal Care, 11/17/09    Relevance Score: 93%

Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease
Nephrology Dialysis Transplantation, 11/12/09    Relevance Score: 93%

Rapid Decline of Kidney Function Increases Cardiovascular Risk in the Elderly
Journal of the American Society of Nephrology, 11/09/09    Relevance Score: 93%

Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events
Clinical and Experimental Nephrology, 11/06/09    Relevance Score: 93%

Today in Cardiology...keeping you current

Smoking intensity and lipoprotein abnormalities in active smokers
Journal of Clinical Lipidology, 12/20/09

Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation
Scandinavian Journal of Clinical and Laboratory Investigation, 12/20/09

Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Is Increased in Human Left Ventricle after Acute Myocardial Infarction
Archives of Medical Research, 12/20/09

Today in Nephrology/Urology...keeping you current

Biological variation of cystatin C and creatinine
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09

Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09

Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection
The Journal of Urology, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address